Resources

Organisation Administrators can add new users to the Government Provider Management System Approved Provider Portal. Follow this procedure to learn how to add a user to the portal.

This update provides a summary of the system changes for My Aged Care systems delivered from 23 March 2026.

Aged Care Financial Report – Non-uploadable template

Aged Care Financial Report data definitions.

This brochure includes information about MyMedicare for your patients.

This fact sheet provides information about biosimilar brands of etanercept listed on the Pharmaceutical Benefits Scheme (PBS).

This fact sheet provides information about biosimilar brands of adalimumab listed on the Pharmaceutical Benefits Scheme (PBS).

We are making changes to residential aged care so older people will have more choice. Find out about the changes and what they mean for you.

This document provides answers to the questions raised during the Living well in care – A conversation for older people webinar held on 26 February 2026.

This document provides a list of biosimilar medicines that are subsidised under the Pharmaceutical Benefits Scheme (PBS).

This fact sheet provides information about biosimilar brands of infliximab listed on the Pharmaceutical Benefits Scheme (PBS).

We are making changes to residential aged care so older people will have more choice. Find out about the changes and what they mean for residential aged care providers.

This fact sheet provides information about biosimilar brands of omalizumab listed on the Pharmaceutical Benefits Scheme (PBS).

This fact sheet provides information about biosimilar brands of aflibercept listed on the Pharmaceutical Benefits Scheme (PBS).

This fact sheet provides information about biosimilar brands of denosumab listed on the Pharmaceutical Benefits Scheme (PBS).

This kit has information, communication resources, articles and social media posts about vaping, which we encourage you to share with young people in your community

This guide provides clear and practical instructions for residential aged care providers on how to report offline beds.

This fact sheet provides information about biosimilar brands of ustekinumab listed on the Pharmaceutical Benefits Scheme (PBS).

This document provides guidance to pharmacists who wish to make an application to establish a new pharmacy or relocate an existing pharmacy, approved to supply pharmaceutical benefits.

This provides information on care minutes performance for residential care homes by financial years. From 1 April 2026, quarterly performance will be used to calculate the care minutes supplement for non-specialised metropolitan homes.

This document provides a list of biosimilar medicines that have been approved by the Therapeutic Goods Administration for supply in Australia.

Quarterly Financial Report frequently asked questions for residential aged care providers to use as a guide when collating their labour costs and hours financial information.